St. Jude Tempo pacemaker shipments under way the week of Jan. 12 following approval of Sylmar facility.
This article was originally published in The Gray Sheet
Executive SummaryST. JUDE TEMPO PACEMAKER SHIPMENTS UNDER WAY THE WEEK OF JAN. 12 following a build-up of inventory at the company's Pacesetter unit manufacturing facility in Sylmar, California. The firm received FDA approval for the Tempo, which incorporates "fifth generation" Minute Ventilation sensor technology, via premarket approval application supplement in August 1997, but decided to defer production until receiving an additional PMA supplement approval to manufacture at the Sylmar site Oct. 16. The systems will cost up to an average of $6,000, depending on model and purchase volume, St. Jude states.
You may also be interested in...
The physician who led the first first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.
The disruptive medtech M&A of recent years was not matched in the past year for volume, but there were isolated outbreaks of major activity, as shown in our company rankings.
Hikma and Civica Rx have announced the launch of a first wave of eight essential injectable medicines, including heparin, as part of a deal struck between the two firms earlier this year.